Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Look in the 10q they have it in there what they are planning on using the money for
Try not to use the word reverse split, as you found out some will take it that you’re a basher and trying to lower the price.
As for what I think. If they do a reverse split it won’t happen for awhile the share structure here is actually pretty good for a pharmaceutical research company for treating cancer that’s in the OTC
Why would they do a reverse split, to bump the share price up and move into the NASDAQ.
The share count doesn’t necessarily matter all that much, just so the share price can stay above a certain amount.
To join the NASDAQ the company has to meet certain requirements, which I don’t know all of them. You will have to look that up.
So as for a reverse happening, if it happens it won’t be for a couple of years
No not anytime soon. If they do one it won’t be for a couple of years plus or minus a year.
Outstanding shares- 411million
Authorized shares-950 million
You can find the the float on otcmarkets.com
For a start up company in the OTC this a decent share count
Go to otcmarkets.com
More
Good for you,
Honestly anything under .50 is a steal my opinion of course
I hope so too, If you have enough shares hold onto even a small amount if you can for a year or two or more and I do believe we will be on the NASDAQ and sitting at $25 plus a share.
Remember human trials will only last 12-18 months, if approved Mayo Clinic will be our first customer with future purchases.
Then the second indication ide application will be submitted. Have no idea what the second application will be. If that gets approved then they will apply for a wide spread use for the rest of the types of cancers to be treated.
So in roughly about 4-5yrs this coupe fully approved for all 18 cancers that they have indicated use for.
Then don’t forget about isopet, hopefully by then it will be a million plus revenue maker by then.
Then also anything everything to do with the overseas market, which I believe once thyroid is approved they will start the process of getting it approved across the pond’s.
All my opinion of course, and yes a buyout and or partnership is very possible.
Second quarter
Definitely
The more the better, hopefully true believers in this also are sharing with their vets as well.
I believe isopet can make some decent consistent revenue if they had a lot more locations.
Lots of people will do just about anything for their pets, but they have limits when it comes to traveling. Most can’t take a few days off work for several hours of traveling plus hotels and such. Adds up quickly.
Time will tell
But I believe within the year, we will finally start see some consistency in isopet.
Ide approval.
My opinion it’ll probably hit a high of at least $5 a share with the excitement and then probably settle down to around $3.00 a share after the excitement fades. Plus or minus a dollar.
This also depends on how high we are before the submission. I would like to see .30-.50 range before submission.
All opinions of course.
Granted there’s still a lot of unknowns, like will the first couple of Bezinga articles do any good. They do have a large following and subscribers.
Some believe share structure will affect the price, which is bs. This is the OTC and a FDA cancer play.
Slim to none
lol, thanks
Actually there’s several plus longs that are way more knowledgeable than me.
And actually these longs have been reaching out to traders that have large followings.
They have let’s just say a file full of information about RDGL ready to send/paste on anyone’s social page.
They have had several positive responses but have no idea how many new investors that have actually bought.
I believe that many traders are waiting until the last minute to jump in.
So if anyone knows of big whales/ or groups that have large following of traders
Post them on here. Some of the longs still get on iHub to see how things are going.
So they will see the names and will look into it.
We have found out that some groups won’t touch the OTC no matter what.
Actually for IDE it’s only 30 days, but since they took the EFS path and also have the BDD which helps get expedited reviews and meetings.
Thats why I’m saying that they should get a response within 10-15 days after submitting.
What will also determine the time frame is how many participants the FDA will require which should only be between 10-15 patients. But more along the lines of how fast the Mayo Clinic can find the required amount of patients.
If you’re talking about human trials.
Depends if ide doesn’t get submitted until end of June then possibly a full 30 days for FDA to look at and decide if it passes.
My opinion this will only take 10-15 days at most. If FDA approves IDE
I’m guessing around 30-60days after IDE approval they will start human trials. So at the earliest August/September for human trials to begin. Granted I have no clue what the Mayo will have to do before they can start trials. Training has already been completed to use Radiogel which is required by the FDA I believe.
As for human market figure 12-18 months after human trials start.
My opinion of course. Could happen sooner or later
Probably a bit early for most.
And unfortunately because of a few bashers that were constantly spewing lies non stop brought in a few longs that would counter their lies and with both it became somewhat comical and uneventful.
There was few real conversations about the company.
But now that this has started moving up, a couple of the bashers have since disappeared.
I believe this scared traders away to other boards like X and stock twits, granted I’ve heard stock twits is pretty quiet as well.
If you don’t already know Mondays and Tuesdays usually seem to be slow to start with some pullback early then late afternoon it picks up. Time will tell
With the otc it can be difficult to figure out the trends and reading charts can be difficult as well to try and predict what will happen next. Especially since this is moving now based on the company submitting the IDE some time in the second quarter.
I’m guessing volume will really start to pick up the last few days of May and continue until submitting.
All my opinions
I don’t think people understand what radiogel is all about.
These extremely low share price estimates are honestly laughable.
Lots of eyes on this that have been waiting for years for this to happen.
My opinion is that we have at least until the first week in June before the PR for submission drops.
Now that the MMs are done sucking up the 11 million shares from the offering that hit the outstanding shares count last week, this will start moving again hopefully just as good as it did on Friday maybe even better.
We have 3 weeks until June, I’m guessing the Bezinga article will finally come out with in the next 2 weeks, don’t expect anything major come out for news from this article, it’s more about getting the word out to new eyes. The second article will come out shortly after and give more details of what’s going on with isopet and vivos and maybe just maybe a better timeframe for the IDE submission.
So this can easily be sitting at around .50 cents plus before submission especially if we can get 20 to 40 percent gains a week before submitting.
This is only a FDA play right now and many are looking for the next best pharmaceuticals play in the market.
I promise you that there’s plenty of traders looking to put this in their portfolios and don’t forget brokerage firms as well
There has been no major and constant whales buying this yet as well. To me a WHALE is 250,000 shares plus.
Time will tell and obviously this is my opinion.
Unfortunately moving to the NASDAQ won’t be happening for awhile. Hopefully within the next year.
I do know that the company does want to make that move. But they aren’t even close meeting any of the requirements yet.
There is no news. The quarterly came out yesterday and that’s it.
No time frame on when the reviews will be completed.
All we know is submittal of the IDE can happen between now and the end of June.
They more than likely will not put out any updates on that end of it.
We might get lucky and maybe get a little heads up before they actually put out the PR for the submittal
Human trials, and since this is a device. The trial period is way shorter.
12-18 months plus or minus a few months
A lot depends on how many patients the FDA will require and how fast the Mayo Clinic can get them.
Very possible, there is 3 weeks left.
Now if we can just get the day traders and MMs to just let this finally go
Welcome to the wonderful world of the OTC.
We should be at a minimum 100 million dollar market cap with isopet alone, but here in otc land they just don’t give a shit.
Day traders control this now until major pr hits,
Which isn’t a bad thing, they will push the price up forcing new traders to buy in higher.
We all know major news is coming so until then the day traders control this
Buyout if it happens
1. Won’t happen until after phase 2 approval the earliest more than likely after full approval. This increases the cost of buyout exponentially considering that they will be able to get approval on several other indications fairly easily once thyroid use is approved.
2. Agree if buyout happens it will be $5 plus per share. The doctor knows what he has especially after approval.
3. Why extend the docs contract another 2yrs.
4. Dr. K doesn’t have the sole authority to sell the company.
Thanks for the post very informative and hopefully everyone sees this post, especially the new traders.
I believe this would answer a lot their questions. Especially when it comes down to the big question
What do they have left to do before they can submit.
Sounds like a lot of paperwork and crossing the Ts and dotting the I’s and making sure it’s all in order.
Depends on how big the offering is for.
The last couple of offerings had no affect on the share price. If there is a drop it won’t be much.
If this stays steady above a dollar after ide approval, the offering will be relatively small. Remember the doc only goes after exactly what he needs and he doesn’t over extend.
The other possibility here is that hopefully isopet might start bringing in real strong consistent revenue to help out. It’ll be minor but every little bit helps.
Also for an OTC the share structure is actually pretty good we are still under 400 million outstanding shares, we aren’t even halfway to the 900 million authorized shares.
But for now everything is a guessing game.
No one believed we would go from .06 to just under .20 with no news other than that they are submitting the ide in the second quarter. We are only one month into the second quarter. People are itching and trying to time it right to jump in.
In time.
With IDE approval, radiogel can start human trials.
And before you say that will take years. It will not take years.
Radiogel went the path of EFS IDE and also got approved for the BDD.
Also radiogel is a device. So in short what all of this means is that radiogel if approved could be on the market anywhere from 8-18months.
Also there’s 18 other indications/types of cancers that they are looking to use this on.
Thyroid is the first one they are looking to treat, which for difficulty of treating this is in the middle.
So once approved, there’s several other cancer types that will get approval fairly quickly.
Short term pricing
Ide submittal - .75 to 1.50 possibly higher
Ide approval - 1.25 to 5.00
Phase 1 human trials approval 1.50 - 5.00
Phase 2 human trials approval 2.00 - 5.00
Phase 3 human trials approval 5.00 plus
While all of this is going on isopet will continue to grow and good possibility they will start bringing in consistent revenue and more than likely have a dozen to two dozen clinics for animal use.
So long term if this doesn’t get bought out. This could easily be a $50 a share plus on the NASDAQ.
I’m guessing with approval this will be on the NASDAQ within the next 18 months with a price of at least 5 to 15 dollars a share.
IDE is the application for the FDA to review.
The IDE application will contain all of the testing and data collected that Radiogel has been requested to do by the FDA.
When radiogel submits the IDE application for review the FDA has 30 days to respond if no response in 30 days they have passed, but the FDA can respond sooner than 30 days as well.
Sell off was day traders taking profits and helping a much needed correction, just didn’t think it was going to drop as much as it did.
We had almost 3 straight weeks of major gains with little to no pullbacks.
I was ready for a pullback today just not that much of a pullback
Day traders taking profits, and just a decent reset before next run.
No bad news has come out.
Monthly update will be posted on new website at 3pm pacific time.
I was expecting a pullback today but not that much of a pullback.
Guess day traders over extended and needed their money back
Agree, this is trading pretty nicely with pullbacks and trading sideways at the right times
Most are not planning on selling all of their shares, they will sell some at certain levels.
1. IDE submittal
2. Hopefully IDE approval
3. Start of human trials
4. Human use approval.
Buyout won’t happen for at least a couple of years if it even happens. The doctor wants this to actually be used and not buried like some larger pharmaceutical companies will do.
Besides they pretty much have a guaranteed customer with the Mayo Clinic. They are doing the human trials and if successful I’m sure they will be the main users.
There’s probably 30 plus longs that have well over 50 million shares combined alone. Thats just the ones that post regularly on here, stocktwits, and X.
All depends on where the price is at when they drop the PR for the ide submittal.
As for when they submit the ide it will happen in the next 60days
If the trend continues and we keep gaining 25 plus percent each week before the submittal happens we could be sitting anywhere from. .30 to .70 cents a share by the time they submit the ide. As long as this trend continues.
First they have to submit the ide application which will happen this quarter.
Once submitted the fda has 30 days to pass and or deny the ide.
So in short by the company timeline there’s roughly 60 days until the end of the quarter and another possible 30 days for fda review.
So at most 90 days give or take a few days.
$100 dollars a share well we are in the otc and anything is possible.
I do agree that we could easily see $5-$10 within the year maybe even sooner.
The way this is climbing right now we could easily be sitting around .50 cents a share before the ide submittal pr drops.
This is moving very nicely, we get our run up for a few days then it pulls back some and or trades sideways for awhile